5.975
Precedente Chiudi:
$6.17
Aprire:
$6.13
Volume 24 ore:
738.40K
Relative Volume:
0.37
Capitalizzazione di mercato:
$797.12M
Reddito:
$3.24B
Utile/perdita netta:
$-66.64M
Rapporto P/E:
-11.26
EPS:
-0.5308
Flusso di cassa netto:
$219.38M
1 W Prestazione:
-0.75%
1M Prestazione:
+4.82%
6M Prestazione:
-53.06%
1 anno Prestazione:
-35.27%
Adapthealth Corp Stock (AHCO) Company Profile
Nome
Adapthealth Corp
Settore
Industria
Telefono
610-424-4515
Indirizzo
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
AHCO
Adapthealth Corp
|
5.975 | 797.12M | 3.24B | -66.64M | 219.38M | -0.5308 |
|
ABT
Abbott Laboratories
|
103.39 | 178.90B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
95.97 | 122.76B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
307.72 | 118.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
45.44 | 65.85B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.69 | 51.70B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-08 | Downgrade | Jefferies | Buy → Hold |
| 2023-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-05-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-05-10 | Downgrade | Stifel | Buy → Hold |
| 2023-05-09 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-07-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-03-18 | Iniziato | Truist | Buy |
| 2021-01-26 | Iniziato | BofA Securities | Buy |
| 2020-12-10 | Iniziato | UBS | Buy |
| 2020-08-10 | Iniziato | Canaccord Genuity | Buy |
| 2020-07-01 | Ripresa | SVB Leerink | Outperform |
| 2020-06-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-01-31 | Iniziato | Stifel | Buy |
| 2020-01-07 | Iniziato | Jefferies | Buy |
| 2019-12-11 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Iniziato | Deutsche Bank | Buy |
Mostra tutto
Adapthealth Corp Borsa (AHCO) Ultime notizie
AdaptHealth (Nasdaq:AHCO)Stock Analysis - simplywall.st
AdaptHealth (NasdaqCM:AHCO) Stock Forecast & Analyst Predictions - simplywall.st
Currie Harriss T Awarded 141,372 Shares of AdaptHealth Corp, Establishing New Insider Stake - Kalkine Media
AdaptHealth CFO Harriss T. Currie Granted 141,372 Restricted Stock Units - Kalkine Media
AdaptHealth To Participate in Upcoming Investor Conferences - Yahoo Finance
Truist reiterates Buy on AdaptHealth stock after CFO change By Investing.com - Investing.com South Africa
Truist reiterates Buy on AdaptHealth stock after CFO change By Investing.com - Investing.com South Africa
Truist reiterates Buy on AdaptHealth stock after CFO change By Investing.com - Investing.com Nigeria
People on the Move: Harriss Currie Named Chief Financial Officer of AdaptHealth - BioBuzz
Why AdaptHealth (AHCO) Stock Is Down Today - finance.yahoo.com
AdaptHealth (NASDAQ: AHCO) Appoints Harriss Currie as CFO with $670,000 Salary and $818K in Stock Units - Kalkine Media
Why AdaptHealth (AHCO) Stock Is Down Today - TradingView
Truist reiterates Buy on AdaptHealth stock after CFO change - investing.com
Truist reiterates Buy on AdaptHealth stock after CFO change By Investing.com - Investing.com India
Truist reiterates Buy on AdaptHealth stock after CFO change By Investing.com - Investing.com Canada
Price-Driven Insight from (AHCO) for Rule-Based Strategy - Stock Traders Daily
AdaptHealth Names Chief Financial Officer - marketscreener.com
AdaptHealth (AHCO) taps new CFO with $670,000 salary - Stock Titan
AdaptHealth names Harriss Currie as chief financial officer - investing.com
AdaptHealth names Harriss Currie as chief financial officer By Investing.com - Investing.com India
AdaptHealth names Harriss Currie as chief financial officer By Investing.com - Investing.com UK
A new finance chief takes over Sept. 9; the current CFO helps through Oct. 1 at AdaptHealth. - Stock Titan
Adapthealth Stock Price Forecast. Should You Buy AHCO? - StockInvest.us
Senior Health, Home Health & Hospice Stocks Q2 Recap: Benchmarking AdaptHealth (NASDAQ:AHCO) - Yahoo Finance
AdaptHealth Tries To Reset After A Tough 2026 - Finimize
Senior Health, Home Health & Hospice Stocks Q2 Recap: Benchmarking AdaptHealth (NASDAQ:AHCO) - The Globe and Mail
Responsive Playbooks and the AHCO Inflection - Stock Traders Daily
Grabar Law Office Investigates Claims on Behalf of Long-term Shareholders of Adapthealth Corp. (AHCO) as Securities Fraud Class Case Heads to Settlement Mediation - TMX Newsfile
AdaptHealth Wins First OK For $14.3M NC Overbilling Deal - Law360
AdaptHealth Wins First OK For $14.3M NC Overbilling Deal - Law360
Bronstein, Gewirtz & Grossman, LLC Encourages AdaptHealth Corp. (AHCO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth C - The National Law Review
AdaptHealth (NASDAQ:AHCO) Faces Pressure After Weak Quarterly Results - kalkinemedia.com
AdaptHealth breach exposed health records of one in 13 Vermonters - Vermont Daily Chronicle
AdaptHealth Breach Exposed Health Records of One in 13 Vermonters - Compass Vermont
AdaptHealth breach exposed health records of one in 13 Vermonters - Vermont Daily Chronicle
AdaptHealth Corp. (NASDAQ:AHCO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
AdaptHealth (AHCO) Closing Note: Falls 1.12% to $5.75 in the Current Update; Boundary Check - Vinanet
AdaptHealth's Market Cap Drops To US$696m Leaving Insiders With Losses - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
AdaptHealth Corp. (AHCO) Q2 2026 Earnings: EPS Misses Estimates by 48.1% on Unreported RevenueNet Profit Margin - vinanet.vn
2026-08-16 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Investors to Learn More About the Investigation | NDAQ:AHCO | Press Release - Stockhouse
AdaptHealth (NASDAQ:AHCO) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
AdaptHealth Corp. (AHCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of ... - Caledonian Record
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information - GlobeNewswire
AdaptHealth Director Dale B. Wolf Updates Stock Purchase Price in Amended SEC Filing - Kalkine Media
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect - The National Law Review
Adapthealth Corp Azioni (AHCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Adapthealth Corp Azioni (AHCO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| WOLF DALE B | Director |
Aug 07 '26 |
Buy |
5.86 |
20,000 |
117,200 |
34,000 |
| WOLF DALE B | Director |
Aug 06 '26 |
Buy |
6.37 |
20,000 |
127,400 |
143,234 |
| Schuster III Russell E. | Chief Commercial Officer |
Jul 01 '26 |
Sale |
10.44 |
11,275 |
117,711 |
125,263 |
| Schuster III Russell E. | Officer |
Jul 01 '26 |
Proposed Sale |
10.44 |
11,275 |
117,711 |
0 |
| Schuster III Russell E. | Chief Commercial Officer |
Jun 01 '26 |
Sale |
10.06 |
11,275 |
113,426 |
136,538 |
| Schuster III Russell E. | Officer |
Jun 01 '26 |
Proposed Sale |
10.06 |
11,275 |
113,426 |
0 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 20 '26 |
Buy |
9.91 |
447,100 |
4,431,700 |
16,312,698 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 19 '26 |
Buy |
9.94 |
727 |
7,228 |
15,865,598 |
| Prast Albert A. | Chief Technology Officer |
Mar 13 '26 |
Option Exercise |
4.38 |
89,451 |
391,795 |
532,358 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 12 '26 |
Buy |
9.73 |
689,336 |
6,707,170 |
15,864,871 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):